| Diversity & Inclusion Events Have Halted. Our Conversations Shouldn’t. | Ramsey Johnson | 06/22/20 | Boston |
| Digital Health Survivors & Innovative Incumbents Must Team Up for True Disruption | Bryony Winn | 12/04/19 | Raleigh Durham |
| Partner or Die: How to Succeed Even After the Digital Health Hype Quiets Down | Rob Coppedge | 12/03/19 | Seattle |
| 3 Changes We Should Make to Address the Gender Pay Gap in Medicine | Alex Harding | 11/06/19 | Boston |
| Drug Pricing: Innovation, Investment, and the Public Good | Johannes Fruehauf | 09/24/19 | Boston |
| The Role of the Student Engineer in Medicine and Innovation | Kevin Eliceiri | 03/18/19 | Wisconsin |
| 7 Tips for Biotech Companies Seeking Capital in a Volatile Market | Cynthia Mazareas and Craig Hilts | 02/28/19 | National |
| Cancer Cures and the Importance of Communicating Responsibly | Carin Canale-Theakston | 02/04/19 | San Diego |
| NY’s Research Institutions Must Keep Working Together in ‘19 | Orin Herskowitz | 12/31/18 | New York |
| Human Space Travel as a Platform to Accelerate Biomedical Innovation | Emilia Javorsky | 11/19/18 | National |
| CEOs and Scientific Founders: Tips for a Long and Successful Marriage | Orin Herskowitz | 11/13/18 | New York |
| Biotech Beware, Your Culture Is Showing | Joanne Kamens | 06/15/18 | Boston |
| Biotech’s Looming Talent Crisis: 5 Ways to Prepare for the Storm | Robin Toft | 06/05/18 | San Diego |
| Fixing the Clinical Trial Bottleneck by Making Patients a Priority | Andreas Koester | 05/21/18 | San Diego |
| The Revolution in Inflammation Drug Development | Gary Glick | 05/15/18 | Boston |
| The Life Science Industry Shows the Power of Giving Back to the Community | Rob Perez | 04/30/18 | Boston |
| U.S. Funding for Biomedical Research Takes Upturn | Bassil Dahiyat & Joseph Panetta | 04/17/18 | San Diego |
| Pay It Forward: Capital Drives Bio Innovation in San Diego & Beyond | Keith Murphy | 02/06/18 | San Diego |
| On Drug Pricing: FDA Backs Up Its Calls for Increased Competition | Troy Wilson | 08/21/17 | San Diego |
| An Insider’s Guide to Bridging the Biotech Gender Gap | Robin Toft | 08/08/17 | San Diego |
| Unconventional Partners, Like FDA, Can Drive Adoption of New Tech | James Coon | 05/24/17 | Boston |
| Want to Communicate Your Science? First, Step Back | Gene Kinney | 04/19/17 | San Francisco |
| How Battling New Epidemics Helps Fight Age-Old Killers | Mark Orr | 04/03/17 | Seattle |
| Dear Tom Price: Bundled Payments Help Patients and Reduce Costs | Alex Harding | 02/11/17 | Boston |
| Biopharma Industry, Heal Thyself (Without Government Help) | Standish Fleming | 01/06/17 | San Diego |
| Watching for NIH Innovation in 2017—and Drug Pricing, Trade Deals | Joe Panetta | 01/02/17 | San Diego |
| Wake Up, Pharma—Trump Is Not Your Savior | Alex Harding | 12/08/16 | Boston |
| Should We Rewrite the Human Genome? | Alex Harding | 11/28/16 | Boston |
| How to Lower Drug Prices, Improve Care, and Save Pharma | Standish Fleming | 11/17/16 | San Diego |
| Sanofi’s Experience With Dengvaxia May Speed Development of Zika Vaccine | Alex Harding | 11/04/16 | Boston |
